Identification and Validation of TEAD Family’s Prognostic Effects and Immune Microenvironment Regulations in Glioma

Background. Gliomas are primary malignant tumors of the central nervous system. The TEA domain transcription factor (TEAD) family proteins are the ultimate effector molecules of the Hippo pathway. However, their expression and function in gliomas have not been further studied. Methods. This study em...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhengyuan Huo, Shaorui Gu, Zheng Bian, Wenli Wang, Zhifeng Jiang
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:International Journal of Clinical Practice
Online Access:http://dx.doi.org/10.1155/2024/7113457
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832546120410071040
author Zhengyuan Huo
Shaorui Gu
Zheng Bian
Wenli Wang
Zhifeng Jiang
author_facet Zhengyuan Huo
Shaorui Gu
Zheng Bian
Wenli Wang
Zhifeng Jiang
author_sort Zhengyuan Huo
collection DOAJ
description Background. Gliomas are primary malignant tumors of the central nervous system. The TEA domain transcription factor (TEAD) family proteins are the ultimate effector molecules of the Hippo pathway. However, their expression and function in gliomas have not been further studied. Methods. This study employed R software as the primary analysis tool. Public databases were used to analyze the expression and prognostic significance of TEADs. Functional enrichment analyses were conducted to determine the functions of the TEADs. We then explored their interaction with tumor-infiltrating immune cells and immune checkpoint proteins (ICPs). A Cox regression model was used to estimate the prognostic value of the TEADs. Finally, we conducted experiments to confirm TEAD3’s function in vitro. Results. TEAD expression was frequently increased in glioma and other malignant tumors. High TEAD expression was found to be substantially linked with isocitrate dehydrogenase (IDH) wild type, noncodeletion of 1p/19q, high WHO grade, and poor prognosis in glioma patients. Functional analyses revealed TEAD involvement in cancer cell transcription. The high expression of TEADs was greatly related to the myeloid-derived suppressor cells (MDSCs) and regulatory T-cells (Tregs) infiltration. TEADs also showed significant correlations with ICP expression in glioma tissues. The Cox regression model demonstrated significant diagnostic and prognostic efficacy in glioma patients. The reduction in TEAD3 affects tumor cell proliferation, migration, invasion, and immune regulation. RNA sequencing disclosed that TEAD3 regulates immune-related pathways, including negative regulation of the CTLA4 inhibitory pathway. Higher TEAD3 expression portended shorter overall survival (OS) and disease-free survival (DFS) in patients with gliomas based on clinical samples. Conclusions. TEADs are overexpressed in gliomas and are associated with a poor prognosis. Importantly, this study discovered that TEADs influence the immunological milieu of glioma by modulating genes associated with immune infiltration.
format Article
id doaj-art-2ec38c51ea684a70b6e004a10c3731ac
institution Kabale University
issn 1742-1241
language English
publishDate 2024-01-01
publisher Wiley
record_format Article
series International Journal of Clinical Practice
spelling doaj-art-2ec38c51ea684a70b6e004a10c3731ac2025-02-03T07:23:47ZengWileyInternational Journal of Clinical Practice1742-12412024-01-01202410.1155/2024/7113457Identification and Validation of TEAD Family’s Prognostic Effects and Immune Microenvironment Regulations in GliomaZhengyuan Huo0Shaorui Gu1Zheng Bian2Wenli Wang3Zhifeng Jiang4Department of Thoracic SurgeryDepartment of Thoracic SurgeryDepartment of Intensive Care MedicineDepartment of Thoracic SurgeryDepartment of Liver Surgery & TransplantationBackground. Gliomas are primary malignant tumors of the central nervous system. The TEA domain transcription factor (TEAD) family proteins are the ultimate effector molecules of the Hippo pathway. However, their expression and function in gliomas have not been further studied. Methods. This study employed R software as the primary analysis tool. Public databases were used to analyze the expression and prognostic significance of TEADs. Functional enrichment analyses were conducted to determine the functions of the TEADs. We then explored their interaction with tumor-infiltrating immune cells and immune checkpoint proteins (ICPs). A Cox regression model was used to estimate the prognostic value of the TEADs. Finally, we conducted experiments to confirm TEAD3’s function in vitro. Results. TEAD expression was frequently increased in glioma and other malignant tumors. High TEAD expression was found to be substantially linked with isocitrate dehydrogenase (IDH) wild type, noncodeletion of 1p/19q, high WHO grade, and poor prognosis in glioma patients. Functional analyses revealed TEAD involvement in cancer cell transcription. The high expression of TEADs was greatly related to the myeloid-derived suppressor cells (MDSCs) and regulatory T-cells (Tregs) infiltration. TEADs also showed significant correlations with ICP expression in glioma tissues. The Cox regression model demonstrated significant diagnostic and prognostic efficacy in glioma patients. The reduction in TEAD3 affects tumor cell proliferation, migration, invasion, and immune regulation. RNA sequencing disclosed that TEAD3 regulates immune-related pathways, including negative regulation of the CTLA4 inhibitory pathway. Higher TEAD3 expression portended shorter overall survival (OS) and disease-free survival (DFS) in patients with gliomas based on clinical samples. Conclusions. TEADs are overexpressed in gliomas and are associated with a poor prognosis. Importantly, this study discovered that TEADs influence the immunological milieu of glioma by modulating genes associated with immune infiltration.http://dx.doi.org/10.1155/2024/7113457
spellingShingle Zhengyuan Huo
Shaorui Gu
Zheng Bian
Wenli Wang
Zhifeng Jiang
Identification and Validation of TEAD Family’s Prognostic Effects and Immune Microenvironment Regulations in Glioma
International Journal of Clinical Practice
title Identification and Validation of TEAD Family’s Prognostic Effects and Immune Microenvironment Regulations in Glioma
title_full Identification and Validation of TEAD Family’s Prognostic Effects and Immune Microenvironment Regulations in Glioma
title_fullStr Identification and Validation of TEAD Family’s Prognostic Effects and Immune Microenvironment Regulations in Glioma
title_full_unstemmed Identification and Validation of TEAD Family’s Prognostic Effects and Immune Microenvironment Regulations in Glioma
title_short Identification and Validation of TEAD Family’s Prognostic Effects and Immune Microenvironment Regulations in Glioma
title_sort identification and validation of tead family s prognostic effects and immune microenvironment regulations in glioma
url http://dx.doi.org/10.1155/2024/7113457
work_keys_str_mv AT zhengyuanhuo identificationandvalidationofteadfamilysprognosticeffectsandimmunemicroenvironmentregulationsinglioma
AT shaoruigu identificationandvalidationofteadfamilysprognosticeffectsandimmunemicroenvironmentregulationsinglioma
AT zhengbian identificationandvalidationofteadfamilysprognosticeffectsandimmunemicroenvironmentregulationsinglioma
AT wenliwang identificationandvalidationofteadfamilysprognosticeffectsandimmunemicroenvironmentregulationsinglioma
AT zhifengjiang identificationandvalidationofteadfamilysprognosticeffectsandimmunemicroenvironmentregulationsinglioma